Goldsmith Mark A's Form 4 filing
Revolution Medicines, Inc. (RVMD) · filed Nov 26, 2025
- Accession no.
- 0001610717-25-000403
- Filed
- Nov 26, 2025
- Trade date
- Nov 25, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.95M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Goldsmith Mark ACIK 0001246842 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | Common Stock | MOption exerciseAcquired | +60,000 | $4.09 | +$245,400 | 307,863 | Direct | |
| Nov 25, 2025 | Common Stock | SSaleDisposed | −60,000 | $75.08F3 | −$4,504,800 | 247,863 | Direct | |
| Nov 25, 2025 | Common Stock | SSaleDisposed | −3,000 | $75.00 | −$225,000 | 67,424 | Indirect | |
| Nov 25, 2025 | Common Stock | SSaleDisposed | −3,000 | $75.00 | −$225,000 | 67,424 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | Common Stock | MOption exerciseDisposed | −60,000 | $0.00 | $0 | 77,708 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $75.00 to $75.3650. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
Remarks
President and Chief Executive Officer